{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T04:22:16Z","timestamp":1727497336127},"reference-count":145,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,27]]},"DOI":"10.7759\/cureus.70312","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T11:06:15Z","timestamp":1727435175000},"source":"Crossref","is-referenced-by-count":0,"title":["Recent Advances in the Development and Utilization of Nanoparticles for the Management of Malignant Solid Tumors"],"prefix":"10.7759","author":[{"given":"Dhanashri D","family":"Chavan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit R","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vandana M","family":"Thorat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amol S","family":"Shete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarika J","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devkumar D","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05467-z","article-title":"Evaluating intrinsic and non-intrinsic cancer risk factors","volume":"9","author":"Wu S","year":"2018","unstructured":"Wu S, Zhu W, Thompson P, Hannun YA. Evaluating intrinsic and non-intrinsic cancer risk factors. Nat Commun. 2018, 9:3490. 10.1038\/s41467-018-05467-z","journal-title":"Nat Commun"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01702-2","article-title":"Telomerase gene therapy: a remission toward cancer","volume":"39","author":"Quazi S","year":"2022","unstructured":"Quazi S. Telomerase gene therapy: a remission toward cancer. Med Oncol. 2022, 39:105. 10.1007\/s12032-022-01702-2","journal-title":"Med Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-008-9661-9","article-title":"Cancer is a preventable disease that requires major lifestyle changes","volume":"25","author":"Anand P","year":"2008","unstructured":"Anand P, Kunnumakkara AB, Sundaram C, et al.. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. 2008, 25:2097-116. 10.1007\/s11095-008-9661-9","journal-title":"Pharm Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-021-03628-6","article-title":"Nanoparticles for cancer therapy: current progress and challenges","volume":"16","author":"Gavas S","year":"2021","unstructured":"Gavas S, Quazi S, Karpi\u0144ski TM. Nanoparticles for cancer therapy: current progress and challenges. Nanoscale Res Lett. 2021, 16:173. 10.1186\/s11671-021-03628-6","journal-title":"Nanoscale Res Lett"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-018-0133-y","article-title":"New opportunities for nanoparticles in cancer immunotherapy","volume":"22","author":"Park W","year":"2018","unstructured":"Park W, Heo YJ, Han DK. New opportunities for nanoparticles in cancer immunotherapy. Biomater Res. 2018, 22:24. 10.1186\/s40824-018-0133-y","journal-title":"Biomater Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00392-z","article-title":"The therapeutic potential of nanobodies","volume":"34","author":"Jov\u010devska I","year":"2020","unstructured":"Jov\u010devska I, Muyldermans S. The therapeutic potential of nanobodies. BioDrugs. 2020, 34:11-26. 10.1007\/s40259-019-00392-z","journal-title":"BioDrugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nri2216","article-title":"Immunological aspects of cancer chemotherapy","volume":"8","author":"Zitvogel L","year":"2008","unstructured":"Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. Immunological aspects of cancer chemotherapy. Nat Rev Immunol. 2008, 8:59-73. 10.1038\/nri2216","journal-title":"Nat Rev Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.13.5305","article-title":"Side effects of chemotherapy among cancer patients in a Malaysian General Hospital: experiences, perceptions and informational needs from clinical pharmacists","volume":"15","author":"Chan HK","year":"2014","unstructured":"Chan HK, Ismail S. Side effects of chemotherapy among cancer patients in a Malaysian General Hospital: experiences, perceptions and informational needs from clinical pharmacists. Asian Pac J Cancer Prev. 2014, 15:5305-9. 10.7314\/apjcp.2014.15.13.5305","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202110.0011.v1","article-title":"Artificial intelligence and machine learning in precision and genomic medicine","author":"Quazi S","year":"2021","unstructured":"Quazi S. Artificial intelligence and machine learning in precision and genomic medicine. Preprints. 2021, 2021100011. 10.20944\/preprints202110.0011.v1","journal-title":"Preprints"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1477-3155-9-55","article-title":"Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines","volume":"9","author":"Mahapatro A","year":"2011","unstructured":"Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnology. 2011, 9:55. 10.1186\/1477-3155-9-55","journal-title":"J Nanobiotechnology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2018.4","article-title":"Cancer immunotherapy in 2017: the breakthrough of the microbiota","volume":"18","author":"Kroemer G","year":"2018","unstructured":"Kroemer G, Zitvogel L. Cancer immunotherapy in 2017: the breakthrough of the microbiota. Nat Rev Immunol. 2018, 18:87-8. 10.1038\/nri.2018.4","journal-title":"Nat Rev Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2355","article-title":"Adoptive cell transfer: a clinical path to effective cancer immunotherapy","volume":"8","author":"Rosenberg SA","year":"2008","unstructured":"Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat Rev Cancer. 2008, 8:299-308. 10.1038\/nrc2355","journal-title":"Nat Rev Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0985","article-title":"T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy","volume":"4","author":"Melero I","year":"2014","unstructured":"Melero I, Rouzaut A, Motz GT, Coukos G. T-cell and NK-cell infiltration into solid tumors: a key limiting factor for efficacious cancer immunotherapy. Cancer Discov. 2014, 4:522-6. 10.1158\/2159-8290.CD-13-0985","journal-title":"Cancer Discov"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-018-0384-3","article-title":"Toxic side effects of targeted therapies and immunotherapies affecting the skin, oral mucosa, hair, and nails","volume":"19","author":"Lacouture M","year":"2018","unstructured":"Lacouture M, Sibaud V. Toxic side effects of targeted therapies and immunotherapies affecting the skin, oral mucosa, hair, and nails. Am J Clin Dermatol. 2018, 19:31-9. 10.1007\/s40257-018-0384-3","journal-title":"Am J Clin Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2018.1457039","article-title":"Nanoparticles as carriers for drug delivery in cancer","volume":"46","author":"Dadwal A","year":"2018","unstructured":"Dadwal A, Baldi A, Kumar Narang R. Nanoparticles as carriers for drug delivery in cancer. Artif Cells Nanomed Biotechnol. 2018, 46:295-305. 10.1080\/21691401.2018.1457039","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2174\/0929867324666170830113755","article-title":"The clinical translation of organic nanomaterials for cancer therapy: a focus on polymeric nanoparticles, micelles, liposomes and exosomes","volume":"25","author":"Palazzolo S","year":"2018","unstructured":"Palazzolo S, Bayda S, Hadla M, Caligiuri I, Corona G, Toffoli G, Rizzolio F. The clinical translation of organic nanomaterials for cancer therapy: a focus on polymeric nanoparticles, micelles, liposomes and exosomes. Curr Med Chem. 2018, 25:4224-68. 10.2174\/0929867324666170830113755","journal-title":"Curr Med Chem"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2016.05.001","article-title":"Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies","volume":"27","author":"Li W","year":"2016","unstructured":"Li W, Zhang H, Assaraf YG, et al.. Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies. Drug Resist Updat. 2016, 27:14-29. 10.1016\/j.drup.2016.05.001","journal-title":"Drug Resist Updat"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.crhy.2011.06.001","article-title":"Nanomedicine, nanotechnology in medicine","volume":"12","author":"Boisseau P","year":"2011","unstructured":"Boisseau P, Loubaton B. Nanomedicine, nanotechnology in medicine. C R Phys. 2011, 12:620-36. 10.1016\/j.crhy.2011.06.001","journal-title":"C R Phys"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1021\/cr068445e","article-title":"Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications","volume":"108","author":"Laurent S","year":"2008","unstructured":"Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev. 2008, 108:2064-110. 10.1021\/cr068445e","journal-title":"Chem Rev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmatsci.2011.08.003","article-title":"Zero-dimensional, one-dimensional, two-dimensional and three-dimensional nanostructured materials for advanced electrochemical energy devices","volume":"57","author":"Tiwari JN","year":"2012","unstructured":"Tiwari JN, Tiwari RN, Kim KS. Zero-dimensional, one-dimensional, two-dimensional and three-dimensional nanostructured materials for advanced electrochemical energy devices. Prog Mater Sci. 2012, 57:724-803. 10.1016\/j.pmatsci.2011.08.003","journal-title":"Prog Mater Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2018019429","article-title":"Current perspectives on novel drug carrier systems and therapies for management of pancreatic cancer: an updated inclusive review","volume":"35","author":"Bhosale RR","year":"2018","unstructured":"Bhosale RR, Gangadharappa HV, Gowda DV, et al.. Current perspectives on novel drug carrier systems and therapies for management of pancreatic cancer: an updated inclusive review. Crit Rev Ther Drug Carrier Syst. 2018, 35:195-292. 10.1615\/CritRevTherDrugCarrierSyst.2018019429","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2016.04.003","article-title":"Pancreatic cancer: a review","volume":"45","author":"Yabar CS","year":"2016","unstructured":"Yabar CS, Winter JM. Pancreatic cancer: a review. Gastroenterol Clin North Am. 2016, 45:429-45. 10.1016\/j.gtc.2016.04.003","journal-title":"Gastroenterol Clin North Am"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2023v15i4.47401","article-title":"Nanogold as a component of active drugs and diagnostic agents","volume":"15","author":"Bursy D","year":"2023","unstructured":"Bursy D, Stas M, Milinski M, Biernat P, Balwierz R. Nanogold as a component of active drugs and diagnostic agents. Int J App Pharm. 2023, 15:52-9. 10.22159\/ijap.2023v15i4.47401","journal-title":"Int J App Pharm"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.236","article-title":"Advanced pancreatic carcinoma: current treatment and future challenges","volume":"7","author":"Stathis A","year":"2010","unstructured":"Stathis A, Moore MJ. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol. 2010, 7:163-72. 10.1038\/nrclinonc.2009.236","journal-title":"Nat Rev Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.21209","article-title":"Stromal biology of pancreatic cancer","volume":"101","author":"Chu GC","year":"2007","unstructured":"Chu GC, Kimmelman AC, Hezel AF, DePinho RA. Stromal biology of pancreatic cancer. J Cell Biochem. 2007, 101:887-907. 10.1002\/jcb.21209","journal-title":"J Cell Biochem"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0686","article-title":"Tumor-stroma interactions in pancreatic ductal adenocarcinoma","volume":"6","author":"Mahadevan D","year":"2007","unstructured":"Mahadevan D, Von Hoff DD. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2007, 6:1186-97. 10.1158\/1535-7163.MCT-06-0686","journal-title":"Mol Cancer Ther"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2009.89","article-title":"Pancreatic cancer: molecular pathogenesis and new therapeutic targets","volume":"6","author":"Wong HH","year":"2009","unstructured":"Wong HH, Lemoine NR. Pancreatic cancer: molecular pathogenesis and new therapeutic targets. Nat Rev Gastroenterol Hepatol. 2009, 6:412-22. 10.1038\/nrgastro.2009.89","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(11)70210-6","article-title":"Adjuvant treatment of pancreatic cancer","volume":"47","author":"Neoptolemos JP","year":"2011","unstructured":"Neoptolemos JP. Adjuvant treatment of pancreatic cancer. Eur J Cancer. 2011, 47:378-80. 10.1016\/S0959-8049(11)70210-6","journal-title":"Eur J Cancer"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2174\/1389450116666150505154720","article-title":"Current perspectives on novel drug delivery systems and approaches for management of cervical cancer: a comprehensive review","volume":"17","author":"Hani U","year":"2016","unstructured":"Hani U, Osmani RA, Bhosale RR, Shivakumar HG, Kulkarni PK. Current perspectives on novel drug delivery systems and approaches for management of cervical cancer: a comprehensive review. Curr Drug Targets. 2016, 17:337-52. 10.2174\/1389450116666150505154720","journal-title":"Curr Drug Targets"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2174\/1389450117666160613103705","article-title":"Current perspectives on novel drug delivery systems and therapies for management of prostate cancer: an inclusive review","volume":"18","author":"Bhosale RR","year":"2017","unstructured":"Bhosale RR, Gangadharappa HV, Hani U, Ali M Osmani R, Vaghela R, Kulkarni PK, Koganti VS. Current perspectives on novel drug delivery systems and therapies for management of prostate cancer: an inclusive review. Curr Drug Targets. 2017, 18:1233-49. 10.2174\/1389450117666160613103705","journal-title":"Curr Drug Targets"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2012.01.003","article-title":"Recent advances in pathway-targeted cancer drug therapies emerging from cancer genome analysis","volume":"22","author":"Yauch RL","year":"2012","unstructured":"Yauch RL, Settleman J. Recent advances in pathway-targeted cancer drug therapies emerging from cancer genome analysis. Curr Opin Genet Dev. 2012, 22:45-9. 10.1016\/j.gde.2012.01.003","journal-title":"Curr Opin Genet Dev"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20141","article-title":"Cancers with increasing incidence trends in the United States: 1999 through 2008","volume":"62","author":"Simard EP","year":"2012","unstructured":"Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012, 62:118-28. 10.3322\/caac.20141","journal-title":"CA Cancer J Clin"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.03.023","article-title":"Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression","volume":"232","author":"Lei Y","year":"2016","unstructured":"Lei Y, Hamada Y, Li J, et al.. Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression. J Control Release. 2016, 232:131-42. 10.1016\/j.jconrel.2016.03.023","journal-title":"J Control Release"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2014.06.039","article-title":"Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor","volume":"192","author":"Valetti S","year":"2014","unstructured":"Valetti S, Maione F, Mura S, et al.. Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. J Control Release. 2014, 192:29-39. 10.1016\/j.jconrel.2014.06.039","journal-title":"J Control Release"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2016.02.008","article-title":"Survivin-targeted nanoparticles for pancreatic tumor imaging in mouse model","volume":"12","author":"Wang Z","year":"2016","unstructured":"Wang Z, Tong M, Chen X, et al.. Survivin-targeted nanoparticles for pancreatic tumor imaging in mouse model. Nanomedicine. 2016, 12:1651-61. 10.1016\/j.nano.2016.02.008","journal-title":"Nanomedicine"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.07.017","article-title":"Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer","volume":"214","author":"Rosenberger I","year":"2015","unstructured":"Rosenberger I, Strauss A, Dobiasch S, et al.. Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer. J Control Release. 2015, 214:76-84. 10.1016\/j.jconrel.2015.07.017","journal-title":"J Control Release"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.24453","article-title":"Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models","volume":"40","author":"Wang L","year":"2014","unstructured":"Wang L, Zhong X, Qian W, et al.. Ultrashort echo time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models. J Magn Reson Imaging. 2014, 40:1071-81. 10.1002\/jmri.24453","journal-title":"J Magn Reson Imaging"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.08.009","article-title":"Polyethylenimine-coated SPION exhibits potential intrinsic anti-metastatic properties inhibiting migration and invasion of pancreatic tumor cells","volume":"216","author":"Mulens-Arias V","year":"2015","unstructured":"Mulens-Arias V, Rojas JM, P\u00e9rez-Yag\u00fce S, Morales Mdel P, Barber DF. Polyethylenimine-coated SPION exhibits potential intrinsic anti-metastatic properties inhibiting migration and invasion of pancreatic tumor cells. J Control Release. 2015, 216:78-92. 10.1016\/j.jconrel.2015.08.009","journal-title":"J Control Release"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2014.10.008","article-title":"Size and charge of nanoparticles following incubation with human plasma of healthy and pancreatic cancer patients","volume":"123","author":"Caracciolo G","year":"2014","unstructured":"Caracciolo G, Caputo D, Pozzi D, Colapicchioni V, Coppola R. Size and charge of nanoparticles following incubation with human plasma of healthy and pancreatic cancer patients. Colloids Surf B Biointerf. 2014, 123:673-8. 10.1016\/j.colsurfb.2014.10.008","journal-title":"Colloids Surf B Biointerf"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2015.07.049","article-title":"Nanoparticle encapsulation and controlled release of a hydrophobic kinase inhibitor: three stage mathematical modeling and parametric analysis","volume":"494","author":"Lucero-Acu\u00f1a A","year":"2015","unstructured":"Lucero-Acu\u00f1a A, Guzm\u00e1n R. Nanoparticle encapsulation and controlled release of a hydrophobic kinase inhibitor: three stage mathematical modeling and parametric analysis. Int J Pharm. 2015, 494:249-57. 10.1016\/j.ijpharm.2015.07.049","journal-title":"Int J Pharm"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2016.04.013","article-title":"Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery","volume":"12","author":"Fu Q","year":"2016","unstructured":"Fu Q, Hargrove D, Lu X. Improving paclitaxel pharmacokinetics by using tumor-specific mesoporous silica nanoparticles with intraperitoneal delivery. Nanomedicine. 2016, 12:1951-9. 10.1016\/j.nano.2016.04.013","journal-title":"Nanomedicine"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2016.06.048","article-title":"Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer","volume":"103","author":"Zhang B","year":"2016","unstructured":"Zhang B, Jiang T, Shen S, et al.. Cyclopamine disrupts tumor extracellular matrix and improves the distribution and efficacy of nanotherapeutics in pancreatic cancer. Biomaterials. 2016, 103:12-21. 10.1016\/j.biomaterials.2016.06.048","journal-title":"Biomaterials"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2015.08.038","article-title":"Dual drug loaded chitosan nanoparticles-sugar-coated arsenal against pancreatic cancer","volume":"135","author":"David KI","year":"2015","unstructured":"David KI, Jaidev LR, Sethuraman S, Krishnan UM. Dual drug loaded chitosan nanoparticles-sugar-coated arsenal against pancreatic cancer. Colloids Surf B Biointerfaces. 2015, 135:689-98. 10.1016\/j.colsurfb.2015.08.038","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S93835","article-title":"An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line","volume":"10","author":"Yu X","year":"2015","unstructured":"Yu X, Di Y, Xie C, et al.. An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line. Int J Nanomedicine. 2015, 10:6825-34. 10.2147\/IJN.S93835","journal-title":"Int J Nanomedicine"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/J.PROCBIO.2015.10.007","article-title":"Doxorubicin functionalized gold nanoparticles: characterization and activity against human cancer cell lines","volume":"50","author":"Dhamecha D","year":"2015","unstructured":"Dhamecha D, Jalalpure S, Jadhav K. Doxorubicin functionalized gold nanoparticles: characterization and activity against human cancer cell lines. Process Biochem. 2015, 50:2298-306. 10.1016\/J.PROCBIO.2015.10.007","journal-title":"Process Biochem"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2174\/1389450117666160401124133","article-title":"Recent advances in nanosystems and strategies for managing leishmaniasis","volume":"18","author":"Vaghela R","year":"2017","unstructured":"Vaghela R, Kulkarni PK, Osmani RAM, Bhosale RR, Naga Sravan Kumar Varma V. Recent advances in nanosystems and strategies for managing leishmaniasis. Curr Drug Targets. 2017, 18:1598-621. 10.2174\/1389450117666160401124133","journal-title":"Curr Drug Targets"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.4103\/1008-682X.151394","article-title":"Locally-advanced prostate cancer in the elderly: should we revisit our treatment paradigms?","volume":"17","author":"Lughezzani G","year":"2015","unstructured":"Lughezzani G, Buffi NM. Locally-advanced prostate cancer in the elderly: should we revisit our treatment paradigms?. Asian J Androl. 2015, 17:769-70. 10.4103\/1008-682X.151394","journal-title":"Asian J Androl"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5812\/numonthly.9430","article-title":"Molecular pathways in prostate cancer","volume":"5","author":"Mazaris E","year":"2013","unstructured":"Mazaris E, Tsiotras A. Molecular pathways in prostate cancer. Nephrourol Mon. 2013, 5:792-800. 10.5812\/numonthly.9430","journal-title":"Nephrourol Mon"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq174","article-title":"Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21 Suppl 5","author":"Horwich A","year":"2010","unstructured":"Horwich A, Parker C, Bangma C, Kataja V. Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010, 21 Suppl 5:v129-33. 10.1093\/annonc\/mdq174","journal-title":"Ann Oncol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2013.06.002","article-title":"Novel therapeutic approaches for the treatment of castration-resistant prostate cancer","volume":"138","author":"Heidegger I","year":"2013","unstructured":"Heidegger I, Massoner P, Eder IE, et al.. Novel therapeutic approaches for the treatment of castration-resistant prostate cancer. J Steroid Biochem Mol Biol. 2013, 138:248-56. 10.1016\/j.jsbmb.2013.06.002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2402","article-title":"Recurrent gene fusions in prostate cancer","volume":"8","author":"Kumar-Sinha C","year":"2008","unstructured":"Kumar-Sinha C, Tomlins SA, Chinnaiyan AM. Recurrent gene fusions in prostate cancer. Nat Rev Cancer. 2008, 8:497-511. 10.1038\/nrc2402","journal-title":"Nat Rev Cancer"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.03.010","article-title":"Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel","volume":"50","author":"Fitzpatrick JM","year":"2014","unstructured":"Fitzpatrick JM, Bellmunt J, Fizazi K, et al.. Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel. Eur J Cancer. 2014, 50:1617-27. 10.1016\/j.ejca.2014.03.010","journal-title":"Eur J Cancer"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2013.01.062","article-title":"Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles","volume":"34","author":"Wadajkar AS","year":"2013","unstructured":"Wadajkar AS, Menon JU, Tsai YS, et al.. Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles. Biomaterials. 2013, 34:3618-25. 10.1016\/j.biomaterials.2013.01.062","journal-title":"Biomaterials"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.04.025","article-title":"Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer","volume":"209","author":"Thangavel S","year":"2015","unstructured":"Thangavel S, Yoshitomi T, Sakharkar MK, Nagasaki Y. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer. J Control Release. 2015, 209:110-9. 10.1016\/j.jconrel.2015.04.025","journal-title":"J Control Release"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2014.06.040","article-title":"Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer","volume":"35","author":"Yallapu MM","year":"2014","unstructured":"Yallapu MM, Khan S, Maher DM, et al.. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer. Biomaterials. 2014, 35:8635-48. 10.1016\/j.biomaterials.2014.06.040","journal-title":"Biomaterials"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.05.021","article-title":"Docetaxel-carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancer","volume":"471","author":"Hoang B","year":"2014","unstructured":"Hoang B, Ernsting MJ, Murakami M, Undzys E, Li SD. Docetaxel-carboxymethylcellulose nanoparticles display enhanced anti-tumor activity in murine models of castration-resistant prostate cancer. Int J Pharm. 2014, 471:224-33. 10.1016\/j.ijpharm.2014.05.021","journal-title":"Int J Pharm"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2013.06.018","article-title":"Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer- and prostate cancer-bearing experimental mouse models","volume":"65","author":"Badr G","year":"2013","unstructured":"Badr G, Al-Sadoon MK, Rabah DM. Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer- and prostate cancer-bearing experimental mouse models. Free Radic Biol Med. 2013, 65:175-89. 10.1016\/j.freeradbiomed.2013.06.018","journal-title":"Free Radic Biol Med"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2012.11.015","article-title":"Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles","volume":"23","author":"Kasten BB","year":"2013","unstructured":"Kasten BB, Liu T, Nedrow-Byers JR, Benny PD, Berkman CE. Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles. Bioorg Med Chem Lett. 2013, 23:565-8. 10.1016\/j.bmcl.2012.11.015","journal-title":"Bioorg Med Chem Lett"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2013.07.003","article-title":"Ionically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats","volume":"85","author":"Elzoghby AO","year":"2013","unstructured":"Elzoghby AO, Saad NI, Helmy MW, Samy WM, Elgindy NA. Ionically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats. Eur J Pharm Biopharm. 2013, 85:444-51. 10.1016\/j.ejpb.2013.07.003","journal-title":"Eur J Pharm Biopharm"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.9b00481","article-title":"In vitro and in vivo approach of hydrogen-sulfide-responsive drug release driven by azide-functionalized mesoporous silica nanoparticles","volume":"2","author":"Thirumalaivasan N","year":"2019","unstructured":"Thirumalaivasan N, Venkatesan P, Lai PS, Wu SP. In vitro and in vivo approach of hydrogen-sulfide-responsive drug release driven by azide-functionalized mesoporous silica nanoparticles. ACS Appl Bio Mater. 2019, 2:3886-96. 10.1021\/acsabm.9b00481","journal-title":"ACS Appl Bio Mater"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2019.101663","article-title":"Recent cancer incidence trends in Ukraine and short-term predictions to 2022","volume":"65","author":"Ryzhov A","year":"2020","unstructured":"Ryzhov A, Bray F, Ferlay J, et al.. Recent cancer incidence trends in Ukraine and short-term predictions to 2022. Cancer Epidemiol. 2020, 65:101663. 10.1016\/j.canep.2019.101663","journal-title":"Cancer Epidemiol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2019.106338","article-title":"Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer","volume":"144","author":"Karpisheh V","year":"2019","unstructured":"Karpisheh V, Nikkhoo A, Hojjat-Farsangi M, et al.. Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer. Prostaglandins Other Lipid Mediat. 2019, 144:106338. 10.1016\/j.prostaglandins.2019.106338","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.05.043","article-title":"Therapeutic opportunities in colon cancer: focus on phosphodiesterase inhibitors","volume":"230","author":"Mehta A","year":"2019","unstructured":"Mehta A, Patel BM. Therapeutic opportunities in colon cancer: focus on phosphodiesterase inhibitors. Life Sci. 2019, 230:150-61. 10.1016\/j.lfs.2019.05.043","journal-title":"Life Sci"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.11.036","article-title":"Diagnostic value of hematological parameters platelet to lymphocyte ratio and hemoglobin to platelet ratio in patients with colon cancer","volume":"501","author":"Hu Z","year":"2020","unstructured":"Hu Z, Tan S, Chen S, et al.. Diagnostic value of hematological parameters platelet to lymphocyte ratio and hemoglobin to platelet ratio in patients with colon cancer. Clin Chim Acta. 2020, 501:48-52. 10.1016\/j.cca.2019.11.036","journal-title":"Clin Chim Acta"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01318","article-title":"p97: an emerging target for cancer, neurodegenerative diseases, and viral infections","volume":"63","author":"Huryn DM","year":"2020","unstructured":"Huryn DM, Kornfilt DJ, Wipf P. p97: an emerging target for cancer, neurodegenerative diseases, and viral infections. J Med Chem. 2020, 63:1892-907. 10.1021\/acs.jmedchem.9b01318","journal-title":"J Med Chem"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.06.017","article-title":"Engineered nanoparticles for imaging and drug delivery in colorectal cancer","volume":"69","author":"Pavitra E","year":"2021","unstructured":"Pavitra E, Dariya B, Srivani G, et al.. Engineered nanoparticles for imaging and drug delivery in colorectal cancer. Semin Cancer Biol. 2021, 69:293-306. 10.1016\/j.semcancer.2019.06.017","journal-title":"Semin Cancer Biol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117032","article-title":"Molecular mechanisms of curcumin and its analogs in colon cancer prevention and treatment","volume":"239","author":"Selvam C","year":"2019","unstructured":"Selvam C, Prabu SL, Jordan BC, Purushothaman Y, Umamaheswari A, Hosseini Zare MS, Thilagavathi R. Molecular mechanisms of curcumin and its analogs in colon cancer prevention and treatment. Life Sci. 2019, 239:117032. 10.1016\/j.lfs.2019.117032","journal-title":"Life Sci"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/498420","article-title":"Physicochemical properties of nanomaterials: implication in associated toxic manifestations","volume":"2014","author":"Gatoo MA","year":"2014","unstructured":"Gatoo MA, Naseem S, Arfat MY, Dar AM, Qasim K, Zubair S. Physicochemical properties of nanomaterials: implication in associated toxic manifestations. Biomed Res Int. 2014, 2014:498420. 10.1155\/2014\/498420","journal-title":"Biomed Res Int"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3109\/10837450.2015.1116565","article-title":"Preparation and in vitro evaluation of 5-fluorouracil-loaded PCL nanoparticles for colon cancer treatment","volume":"22","author":"\u00d6zt\u00fcrk K","year":"2017","unstructured":"\u00d6zt\u00fcrk K, Mashal AR, Yegin BA, \u00c7al\u0131\u015f S. Preparation and in vitro evaluation of 5-fluorouracil-loaded PCL nanoparticles for colon cancer treatment. Pharm Dev Technol. 2017, 22:635-41. 10.3109\/10837450.2015.1116565","journal-title":"Pharm Dev Technol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.102068","article-title":"Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles","volume":"21","author":"Wang R","year":"2019","unstructured":"Wang R, Huang J, Chen J, et al.. Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles. Nanomedicine. 2019, 21:102068. 10.1016\/j.nano.2019.102068","journal-title":"Nanomedicine"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.01.019","article-title":"Hierarchically targetable polysaccharide-coated solid lipid nanoparticles as an oral chemo\/thermotherapy delivery system for local treatment of colon cancer","volume":"197","author":"Shen MY","year":"2019","unstructured":"Shen MY, Liu TI, Yu TW, et al.. Hierarchically targetable polysaccharide-coated solid lipid nanoparticles as an oral chemo\/thermotherapy delivery system for local treatment of colon cancer. Biomaterials. 2019, 197:86-100. 10.1016\/j.biomaterials.2019.01.019","journal-title":"Biomaterials"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2016.03.005","article-title":"Magnetic solid lipid nanoparticles in hyperthermia against colon cancer","volume":"504","author":"Mu\u00f1oz de Escalona M","year":"2016","unstructured":"Mu\u00f1oz de Escalona M, S\u00e1ez-Fern\u00e1ndez E, Prados JC, Melguizo C, Arias JL. Magnetic solid lipid nanoparticles in hyperthermia against colon cancer. Int J Pharm. 2016, 504:11-9. 10.1016\/j.ijpharm.2016.03.005","journal-title":"Int J Pharm"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2017.10.034","article-title":"Biological evaluation of surface-modified magnetic nanoparticles as a platform for colon cancer cell theranostics","volume":"161","author":"Moskvin M","year":"2018","unstructured":"Moskvin M, Babi\u010d M, Reis S, et al.. Biological evaluation of surface-modified magnetic nanoparticles as a platform for colon cancer cell theranostics. Colloids Surf B Biointerfaces. 2018, 161:35-41. 10.1016\/j.colsurfb.2017.10.034","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2018.01.008","article-title":"Physiological uptake and retention of radiolabeled resveratrol loaded gold nanoparticles ((99m)Tc-Res-AuNP) in colon cancer tissue","volume":"14","author":"Kamal R","year":"2018","unstructured":"Kamal R, Chadha VD, Dhawan DK. Physiological uptake and retention of radiolabeled resveratrol loaded gold nanoparticles ((99m)Tc-Res-AuNP) in colon cancer tissue. Nanomedicine. 2018, 14:1059-71. 10.1016\/j.nano.2018.01.008","journal-title":"Nanomedicine"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.04.060","article-title":"SN38 conjugated hyaluronic acid gold nanoparticles as a novel system against metastatic colon cancer cells","volume":"526","author":"Hosseinzadeh H","year":"2017","unstructured":"Hosseinzadeh H, Atyabi F, Varnamkhasti BS, Hosseinzadeh R, Ostad SN, Ghahremani MH, Dinarvand R. SN38 conjugated hyaluronic acid gold nanoparticles as a novel system against metastatic colon cancer cells. Int J Pharm. 2017, 526:339-52. 10.1016\/j.ijpharm.2017.04.060","journal-title":"Int J Pharm"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2016.04.041","article-title":"Targeted delivery of small interfering RNA to colon cancer cells using chitosan and PEGylated chitosan nanoparticles","volume":"147","author":"Rudzinski WE","year":"2016","unstructured":"Rudzinski WE, Palacios A, Ahmed A, Lane MA, Aminabhavi TM. Targeted delivery of small interfering RNA to colon cancer cells using chitosan and PEGylated chitosan nanoparticles. Carbohydr Polym. 2016, 147:323-32. 10.1016\/j.carbpol.2016.04.041","journal-title":"Carbohydr Polym"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2016.03.069","article-title":"Polyphenol stabilized colloidal gold nanoparticles from Abutilon indicum leaf extract induce apoptosis in HT-29 colon cancer cells","volume":"143","author":"Mata R","year":"2016","unstructured":"Mata R, Nakkala JR, Sadras SR. Polyphenol stabilized colloidal gold nanoparticles from Abutilon indicum leaf extract induce apoptosis in HT-29 colon cancer cells. Colloids Surf B Biointerfaces. 2016, 143:499-510. 10.1016\/j.colsurfb.2016.03.069","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2014.04.017","article-title":"In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies","volume":"88","author":"Anitha A","year":"2014","unstructured":"Anitha A, Sreeranganathan M, Chennazhi KP, Lakshmanan VK, Jayakumar R. In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies. Eur J Pharm Biopharm. 2014, 88:238-51. 10.1016\/j.ejpb.2014.04.017","journal-title":"Eur J Pharm Biopharm"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2015.12.014","article-title":"EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery","volume":"83","author":"Xie X","year":"2016","unstructured":"Xie X, Li F, Zhang H, et al.. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. Eur J Pharm Sci. 2016, 83:28-35. 10.1016\/j.ejps.2015.12.014","journal-title":"Eur J Pharm Sci"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.07.023","article-title":"Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment","volume":"11","author":"Cai H","year":"2021","unstructured":"Cai H, Xiang Y, Zeng Y, et al.. Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment. Acta Pharm Sin B. 2021, 11:544-59. 10.1016\/j.apsb.2020.07.023","journal-title":"Acta Pharm Sin B"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz N","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, et al.. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003, 348:518-27. 10.1056\/NEJMoa021641","journal-title":"N Engl J Med"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jncimonographs.a003476","article-title":"Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia","volume":"31","author":"Schiffman M","year":"2003","unstructured":"Schiffman M, Kjaer SK. Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr. 2003, 31:14-9. 10.1093\/oxfordjournals.jncimonographs.a003476","journal-title":"J Natl Cancer Inst Monogr"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20365","article-title":"Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer","volume":"101","author":"Daling JR","year":"2004","unstructured":"Daling JR, Madeleine MM, Johnson LG, et al.. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer. 2004, 101:270-80. 10.1002\/cncr.20365","journal-title":"Cancer"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.16.1.1-17.2003","article-title":"Human papillomavirus and cervical cancer","volume":"16","author":"Burd EM","year":"2003","unstructured":"Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003, 16:1-17. 10.1128\/CMR.16.1.1-17.2003","journal-title":"Clin Microbiol Rev"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention","volume":"98","author":"Castellsagu\u00e9 X","year":"2006","unstructured":"Castellsagu\u00e9 X, D\u00edaz M, de Sanjos\u00e9 S, et al.. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006, 98:303-15. 10.1093\/jnci\/djj067","journal-title":"J Natl Cancer Inst"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.16.2120","article-title":"2001 Consensus Guidelines for the management of women with cervical cytological abnormalities","volume":"287","author":"Wright TC Jr","year":"2002","unstructured":"Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002, 287:2120-9. 10.1001\/jama.287.16.2120","journal-title":"JAMA"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.07.067","article-title":"Human papillomavirus infection: epidemiology and pathophysiology","volume":"107","author":"Steben M","year":"2007","unstructured":"Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol. 2007, 107:S2-5. 10.1016\/j.ygyno.2007.07.067","journal-title":"Gynecol Oncol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.2174\/1567201811666140825130003","article-title":"Solubility enhancement and delivery systems of curcumin a herbal medicine: a review","volume":"11","author":"Hani U","year":"2014","unstructured":"Hani U, Shivakumar HG. Solubility enhancement and delivery systems of curcumin a herbal medicine: a review. Curr Drug Deliv. 2014, 11:792-804. 10.2174\/1567201811666140825130003","journal-title":"Curr Drug Deliv"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S61670","article-title":"Nanotechnology-based drug delivery systems for treatment of oral cancer: a review","volume":"9","author":"Calixto G","year":"2014","unstructured":"Calixto G, Bernegossi J, Fonseca-Santos B, Chorilli M. Nanotechnology-based drug delivery systems for treatment of oral cancer: a review. Int J Nanomedicine. 2014, 9:3719-35. 10.2147\/IJN.S61670","journal-title":"Int J Nanomedicine"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2014.10.016","article-title":"Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticles","volume":"69","author":"Dixit N","year":"2015","unstructured":"Dixit N, Vaibhav K, Pandey RS, Jain UK, Katare OP, Katyal A, Madan J. Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticles. Biomed Pharmacother. 2015, 69:1-10. 10.1016\/j.biopha.2014.10.016","journal-title":"Biomed Pharmacother"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.bionut.2011.09.003","article-title":"Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells","volume":"1","author":"Krishnakumar N","year":"2011","unstructured":"Krishnakumar N, Sulfikkarali N, Prasad NR, Karthikeyan S. Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (HeLa) cancer cells. Biomed Prev Nutr. 2011, 1:223-31. 10.1016\/j.bionut.2011.09.003","journal-title":"Biomed Prev Nutr"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2009.11.009","article-title":"Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa","volume":"31","author":"Vivero-Escoto JL","year":"2010","unstructured":"Vivero-Escoto JL, Slowing II, Lin VS. Tuning the cellular uptake and cytotoxicity properties of oligonucleotide intercalator-functionalized mesoporous silica nanoparticles with human cervical cancer cells HeLa. Biomaterials. 2010, 31:1325-33. 10.1016\/j.biomaterials.2009.11.009","journal-title":"Biomaterials"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2012.09.042","article-title":"An investigation on the cytotoxicity and caspase-mediated apoptotic effect of biologically synthesized silver nanoparticles using Podophyllum hexandrum on human cervical carcinoma cells","volume":"102","author":"Jeyaraj M","year":"2013","unstructured":"Jeyaraj M, Rajesh M, Arun R, et al.. An investigation on the cytotoxicity and caspase-mediated apoptotic effect of biologically synthesized silver nanoparticles using Podophyllum hexandrum on human cervical carcinoma cells. Colloids Surf B Biointerfaces. 2013, 102:708-17. 10.1016\/j.colsurfb.2012.09.042","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3390\/jfb12040070","article-title":"Gold nanoparticles: biosynthesis and potential of biomedical application","volume":"12","author":"Mikhailova EO","year":"2021","unstructured":"Mikhailova EO. Gold nanoparticles: biosynthesis and potential of biomedical application. J Funct Biomater. 2021, 12:70. 10.3390\/jfb12040070","journal-title":"J Funct Biomater"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2014.03.036","article-title":"Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells","volume":"118","author":"Saini J","year":"2014","unstructured":"Saini J, Bansal V, Chandra A, Madan J, Jain UK, Chandra R, Jain SM. Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells. Colloids Surf B Biointerfaces. 2014, 118:101-10. 10.1016\/j.colsurfb.2014.03.036","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2014.15.21.9249","article-title":"Curcumin-loaded PLGA nanoparticles conjugated with anti-P-glycoprotein antibody to overcome multidrug resistance","volume":"15","author":"Punfa W","year":"2014","unstructured":"Punfa W, Suzuki S, Pitchakarn P, Yodkeeree S, Naiki T, Takahashi S, Limtrakul P. Curcumin-loaded PLGA nanoparticles conjugated with anti-P-glycoprotein antibody to overcome multidrug resistance. Asian Pac J Cancer Prev. 2014, 15:9249-58. 10.7314\/apjcp.2014.15.21.9249","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1021\/bm5013822","article-title":"Long circulating self-assembled nanoparticles from cholesterol-containing brush-like block copolymers for improved drug delivery to tumors","volume":"15","author":"Tran TH","year":"2014","unstructured":"Tran TH, Nguyen CT, Gonzalez-Fajardo L, et al.. Long circulating self-assembled nanoparticles from cholesterol-containing brush-like block copolymers for improved drug delivery to tumors. Biomacromolecules. 2014, 15:4363-75. 10.1021\/bm5013822","journal-title":"Biomacromolecules"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1021\/am5059519","article-title":"In situ monitoring of intracellular controlled drug release from mesoporous silica nanoparticles coated with pH-responsive charge-reversal polymer","volume":"6","author":"Zhang P","year":"2014","unstructured":"Zhang P, Wu T, Kong JL. In situ monitoring of intracellular controlled drug release from mesoporous silica nanoparticles coated with pH-responsive charge-reversal polymer. ACS Appl Mater Interfaces. 2014, 6:17446-53. 10.1021\/am5059519","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.08.018","article-title":"Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation","volume":"474","author":"Xiong Q","year":"2014","unstructured":"Xiong Q, Zhang M, Zhang Z, Shen W, Liu L, Zhang Q. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation. Int J Pharm. 2014, 474:232-40. 10.1016\/j.ijpharm.2014.08.018","journal-title":"Int J Pharm"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S59661","article-title":"Cytotoxic effect of magnetic iron oxide nanoparticles synthesized via seaweed aqueous extract","volume":"9","author":"Namvar F","year":"2014","unstructured":"Namvar F, Rahman HS, Mohamad R, et al.. Cytotoxic effect of magnetic iron oxide nanoparticles synthesized via seaweed aqueous extract. Int J Nanomedicine. 2014, 9:2479-88. 10.2147\/IJN.S59661","journal-title":"Int J Nanomedicine"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2014.10.024","article-title":"Transferrin conjugated poly (\u03b3-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery","volume":"123","author":"Zhao C","year":"2014","unstructured":"Zhao C, Liu X, Liu J, et al.. Transferrin conjugated poly (\u03b3-glutamic acid-maleimide-co-L-lactide)-1,2-dipalmitoylsn-glycero-3-phosphoethanolamine copolymer nanoparticles for targeting drug delivery. Colloids Surf B Biointerfaces. 2014, 123:787-96. 10.1016\/j.colsurfb.2014.10.024","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2014.1791","article-title":"Biocompatible amphiphilic pentablock copolymeric nanoparticles for anti-cancer drug delivery","volume":"10","author":"Byagari K","year":"2014","unstructured":"Byagari K, Shanavas A, Rengan AK, Kundu GC, Srivastava R. Biocompatible amphiphilic pentablock copolymeric nanoparticles for anti-cancer drug delivery. J Biomed Nanotechnol. 2014, 10:109-19. 10.1166\/jbn.2014.1791","journal-title":"J Biomed Nanotechnol"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/193401","article-title":"Anticancer drug-incorporated layered double hydroxide nanohybrids and their enhanced anticancer therapeutic efficacy in combination cancer treatment","volume":"2014","author":"Kim TH","year":"2014","unstructured":"Kim TH, Lee GJ, Kang JH, Kim HJ, Kim TI, Oh JM. Anticancer drug-incorporated layered double hydroxide nanohybrids and their enhanced anticancer therapeutic efficacy in combination cancer treatment. Biomed Res Int. 2014, 2014:193401. 10.1155\/2014\/193401","journal-title":"Biomed Res Int"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.134924","article-title":"Construction and anti-pancreatic cancer activity of selenium nanoparticles stabilized by Prunella vulgaris polysaccharide","volume":"278","author":"Zhang S","year":"2024","unstructured":"Zhang S, Wang Y, Wang M, et al.. Construction and anti-pancreatic cancer activity of selenium nanoparticles stabilized by Prunella vulgaris polysaccharide. Int J Biol Macromol. 2024, 278:134924. 10.1016\/j.ijbiomac.2024.134924","journal-title":"Int J Biol Macromol"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101106","article-title":"VISTA antibody-loaded Fe(3)O(4)@TiO(2) nanoparticles for sonodynamic therapy-synergistic immune checkpoint therapy of pancreatic cancer","volume":"26","author":"Hong L","year":"2024","unstructured":"Hong L, Xu K, Yang M, et al.. VISTA antibody-loaded Fe(3)O(4)@TiO(2) nanoparticles for sonodynamic therapy-synergistic immune checkpoint therapy of pancreatic cancer. Mater Today Bio. 2024, 26:101106. 10.1016\/j.mtbio.2024.101106","journal-title":"Mater Today Bio"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124072","article-title":"Integration of caveolin-mediated cytosolic delivery and enzyme-responsive releasing of squalenoyl nanoparticles enhance the anti-cancer efficacy of chidamide in pancreatic cancer","volume":"655","author":"Chen J","year":"2024","unstructured":"Chen J, Chen K, Xue S, et al.. Integration of caveolin-mediated cytosolic delivery and enzyme-responsive releasing of squalenoyl nanoparticles enhance the anti-cancer efficacy of chidamide in pancreatic cancer. Int J Pharm. 2024, 655:124072. 10.1016\/j.ijpharm.2024.124072","journal-title":"Int J Pharm"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.3c00983","article-title":"Gemcitabine-phospholipid complex loaded lipid nanoparticles for improving drug loading, stability, and efficacy against pancreatic cancer","volume":"21","author":"Dora CP","year":"2024","unstructured":"Dora CP, Kushwah V, Yadav V, Kuche K, Jain S. Gemcitabine-phospholipid complex loaded lipid nanoparticles for improving drug loading, stability, and efficacy against pancreatic cancer. Mol Pharm. 2024, 21:2699-712. 10.1021\/acs.molpharmaceut.3c00983","journal-title":"Mol Pharm"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.122328","article-title":"Curcumin loaded \u03b2-cyclodextrin-magnetic graphene oxide nanoparticles decorated with folic acid receptors as a new theranostic agent to improve prostate cancer treatment","volume":"340","author":"Einafshar E","year":"2024","unstructured":"Einafshar E, Javid H, Amiri H, Akbari-Zadeh H, Hashemy SI. Curcumin loaded \u03b2-cyclodextrin-magnetic graphene oxide nanoparticles decorated with folic acid receptors as a new theranostic agent to improve prostate cancer treatment. Carbohydr Polym. 2024, 340:122328. 10.1016\/j.carbpol.2024.122328","journal-title":"Carbohydr Polym"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138562","article-title":"Caffeic acid phenethyl ester (CAPE) chitosan capped ZnO nanoparticles: preparation, characterization, and its potential for the treatment of prostate cancer","volume":"1312","author":"Ince I","year":"2024","unstructured":"Ince I, Yildirim Y, Goker E. Caffeic acid phenethyl ester (CAPE) chitosan capped ZnO nanoparticles: preparation, characterization, and its potential for the treatment of prostate cancer. J Mol Struct. 2024, 1312:138562. 10.1016\/j.molstruc.2024.138562","journal-title":"J Mol Struct"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2024.106089","article-title":"Deer antler extract-nanoparticles exhibit co-nanozyme activity and targeting of prostate cancer cells","volume":"115","author":"Nazarbek G","year":"2024","unstructured":"Nazarbek G, Mu C, Shaimoldina A. Deer antler extract-nanoparticles exhibit co-nanozyme activity and targeting of prostate cancer cells. J Funct Foods. 2024, 115:106089. 10.1016\/j.jff.2024.106089","journal-title":"J Funct Foods"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117125","article-title":"PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer","volume":"177","author":"Adekiya TA","year":"2024","unstructured":"Adekiya TA, Hudson T, Bakare O, Ameyaw EE, Adebayo A, Olajubutu O, Adesina SK. PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer. Biomed Pharmacother. 2024, 177:117125. 10.1016\/j.biopha.2024.117125","journal-title":"Biomed Pharmacother"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2024.114477","article-title":"Targeted colorectal cancer treatment: in vitro anti-cancer effects of carnosine nanoparticles supported by agar and magnetic iron oxide","volume":"203","author":"Hsieh LC","year":"2024","unstructured":"Hsieh LC, Le TK, Hu FC, Chen YT, Hsieh S, Wu CC, Hsieh SL. Targeted colorectal cancer treatment: in vitro anti-cancer effects of carnosine nanoparticles supported by agar and magnetic iron oxide. Eur J Pharm Biopharm. 2024, 203:114477. 10.1016\/j.ejpb.2024.114477","journal-title":"Eur J Pharm Biopharm"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124622","article-title":"Fucoidan based polymeric nanoparticles encapsulating epirubicin: a novel and effective chemotherapeutic formulation against colorectal cancer","volume":"664","author":"Khan SH","year":"2024","unstructured":"Khan SH, Anees M, Zofair SF, Rasool F, Khan MA, Moin S, Younus H. Fucoidan based polymeric nanoparticles encapsulating epirubicin: a novel and effective chemotherapeutic formulation against colorectal cancer. Int J Pharm. 2024, 664:124622. 10.1016\/j.ijpharm.2024.124622","journal-title":"Int J Pharm"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jafr.2024.101149","article-title":"Moringa oleifera Leaf Powder Silver Nanoparticles (MOLP-AgNPs) efficiently inhibit metastasis and proliferative signaling in HT-29 human colorectal cancer cells","volume":"16","author":"Susanto H","year":"2024","unstructured":"Susanto H, Firdaus SRA, Sholeh M, Endharti AT, Taufiq A, Malek NANN, Permatasari HK. Moringa oleifera Leaf Powder Silver Nanoparticles (MOLP-AgNPs) efficiently inhibit metastasis and proliferative signaling in HT-29 human colorectal cancer cells. J Agric Food Res. 2024, 16:101149. 10.1016\/j.jafr.2024.101149","journal-title":"J Agric Food Res"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/j.sciaf.2024.e02268","article-title":"Anticancer potential of silver nanoparticles biosynthesized using Catharanthus roseus leaves extract on cervical (HeLa229) cancer cell line","volume":"25","author":"Hussein HS","year":"2024","unstructured":"Hussein HS, Ngugi C, Tolo FM, Maina EM. Anticancer potential of silver nanoparticles biosynthesized using Catharanthus roseus leaves extract on cervical (HeLa229) cancer cell line. Sci Afr. 2024, 25:1-16. 10.1016\/j.sciaf.2024.e02268","journal-title":"Sci Afr"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsamd.2024.100774","article-title":"Decorated of silver nanoparticles over Arabic gum modified magnetic nanoparticles: evaluation of its antioxidant and its therapeutic effects on cervical cancer","volume":"9","author":"Li Y","year":"2024","unstructured":"Li Y, Gao N. Decorated of silver nanoparticles over Arabic gum modified magnetic nanoparticles: evaluation of its antioxidant and its therapeutic effects on cervical cancer. J Sci Adv Mater Dev. 2024, 9:1-7. 10.1016\/j.jsamd.2024.100774","journal-title":"J Sci Adv Mater Dev"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1016\/j.nxnano.2024.100105","article-title":"Caffeic acid functionalized silver nanoparticles: a bionanoformulation and its assessment of cell cycle and in vitro cytotoxicity","volume":"7","author":"Pushpanathan S","year":"2025","unstructured":"Pushpanathan S, Yahya S, Gunasekaran A, Natarajan SR, Kannan K, Krishnan K. Caffeic acid functionalized silver nanoparticles: a bionanoformulation and its assessment of cell cycle and in vitro cytotoxicity. Next Nanotechnol. 2025, 7:1-9. 10.1016\/j.nxnano.2024.100105","journal-title":"Next Nanotechnol"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-012-9339-4","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai N","year":"2012","unstructured":"Desai N. Challenges in development of nanoparticle-based therapeutics. AAPS J. 2012, 14:282-95. 10.1208\/s12248-012-9339-4","journal-title":"AAPS J"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1039\/c8nr05933k","article-title":"Polymer nanoparticles for the intravenous delivery of anticancer drugs: the checkpoints on the road from the synthesis to clinical translation","volume":"10","author":"Ferrari R","year":"2018","unstructured":"Ferrari R, Sponchioni M, Morbidelli M, Moscatelli D. Polymer nanoparticles for the intravenous delivery of anticancer drugs: the checkpoints on the road from the synthesis to clinical translation. Nanoscale. 2018, 10:22701-19. 10.1039\/c8nr05933k","journal-title":"Nanoscale"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.9b00228","article-title":"Survey of clinical translation of cancer nanomedicines-lessons learned from successes and failures","volume":"52","author":"He H","year":"2019","unstructured":"He H, Liu L, Morin EE, Liu M, Schwendeman A. Survey of clinical translation of cancer nanomedicines-lessons learned from successes and failures. Acc Chem Res. 2019, 52:2445-61. 10.1021\/acs.accounts.9b00228","journal-title":"Acc Chem Res"},{"key":"ref121","article-title":"Progress in nanomedicine: approved and investigational nanodrugs","volume":"42","author":"Ventola CL","year":"2017","unstructured":"Ventola CL. Progress in nanomedicine: approved and investigational nanodrugs. P T. 2017, 42:742-55.","journal-title":"P T"},{"key":"ref122","article-title":"Magnetic resonance imaging modalities with contrast enhancing nanomaterials","volume":"1","author":"Fymat AL","year":"2017","unstructured":"Fymat AL. Magnetic resonance imaging modalities with contrast enhancing nanomaterials. Curr Trends Clin Med Imaging. 2017, 1:11-14.","journal-title":"Curr Trends Clin Med Imaging"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2014.04.008","article-title":"Drug safety: the concept, inception and its importance in patients' health","volume":"24","author":"Alshammari TM","year":"2016","unstructured":"Alshammari TM. Drug safety: the concept, inception and its importance in patients' health. Saudi Pharm J. 2016, 24:405-12. 10.1016\/j.jsps.2014.04.008","journal-title":"Saudi Pharm J"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-021-01024-2","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","volume":"12","author":"\u0110or\u0111evi\u0107 S","year":"2022","unstructured":"\u0110or\u0111evi\u0107 S, Gonzalez MM, Conejos-S\u00e1nchez I, et al.. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res. 2022, 12:500-25. 10.1007\/s13346-021-01024-2","journal-title":"Drug Deliv Transl Res"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001440","article-title":"Endotoxin: back to the future","volume":"44","author":"Cross A","year":"2016","unstructured":"Cross A. Endotoxin: back to the future. Crit Care Med. 2016, 44:450-1. 10.1097\/CCM.0000000000001440","journal-title":"Crit Care Med"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2020.1831106","article-title":"Recent advances in drug delivery systems for enhancing drug penetration into tumors","volume":"27","author":"He B","year":"2020","unstructured":"He B, Sui X, Yu B, Wang S, Shen Y, Cong H. Recent advances in drug delivery systems for enhancing drug penetration into tumors. Drug Deliv. 2020, 27:1474-90. 10.1080\/10717544.2020.1831106","journal-title":"Drug Deliv"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S75615","article-title":"Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures","volume":"10","author":"Murugan K","year":"2015","unstructured":"Murugan K, Choonara YE, Kumar P, Bijukumar D, du Toit LC, Pillay V. Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures. Int J Nanomedicine. 2015, 10:2191-206. 10.2147\/IJN.S75615","journal-title":"Int J Nanomedicine"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.7150\/thno.47849","article-title":"Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery","volume":"10","author":"Wang S","year":"2020","unstructured":"Wang S, Zhang F, Yu G, et al.. Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery. Theranostics. 2020, 10:6629-37. 10.7150\/thno.47849","journal-title":"Theranostics"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2019.1709919","article-title":"Enhanced cytotoxicity of a redox-sensitive hyaluronic acid-based nanomedicine toward different oncocytes via various internalization mechanisms","volume":"27","author":"Du Y","year":"2020","unstructured":"Du Y, Wang S, Zhang T, He D, Tu J, Shen Y. Enhanced cytotoxicity of a redox-sensitive hyaluronic acid-based nanomedicine toward different oncocytes via various internalization mechanisms. Drug Deliv. 2020, 27:128-36. 10.1080\/10717544.2019.1709919","journal-title":"Drug Deliv"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1002\/pat.5168","article-title":"Targeted delivery, drug release strategies, and toxicity study of polymeric drug nanocarriers","volume":"32","author":"Abasian P","year":"2021","unstructured":"Abasian P, Shakibi S, Maniati MS, Nouri KS, Khalili S. Targeted delivery, drug release strategies, and toxicity study of polymeric drug nanocarriers. Polym Adv Technol. 2021, 32:931-44. 10.1002\/pat.5168","journal-title":"Polym Adv Technol"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco E","year":"2015","unstructured":"Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015, 33:941-51. 10.1038\/nbt.3330","journal-title":"Nat Biotechnol"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.3390\/nano11010036","article-title":"Prunus spinosa extract loaded in biomimetic nanoparticles evokes in vitro anti-inflammatory and wound healing activities","volume":"11","author":"Tiboni M","year":"2021","unstructured":"Tiboni M, Coppari S, Casettari L, et al.. Prunus spinosa extract loaded in biomimetic nanoparticles evokes in vitro anti-inflammatory and wound healing activities. Nanomaterials (Basel). 2021, 11:36. 10.3390\/nano11010036","journal-title":"Nanomaterials (Basel)"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.110298","article-title":"Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: a review","volume":"106","author":"He Z","year":"2020","unstructured":"He Z, Zhang Y, Feng N. Cell membrane-coated nanosized active targeted drug delivery systems homing to tumor cells: a review. Mater Sci Eng C Mater Biol Appl. 2020, 106:110298. 10.1016\/j.msec.2019.110298","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"ref134","doi-asserted-by":"crossref","DOI":"10.2174\/187221413804660926","article-title":"Cancer therapy based on a mechanism of action for controlling the immune system and the resulting patent portfolio","volume":"7","author":"Goswitz VC","year":"2013","unstructured":"Goswitz VC, Sawicki ZP. Cancer therapy based on a mechanism of action for controlling the immune system and the resulting patent portfolio. Recent Pat Endocr Metab Immune Drug Discov. 2013, 7:1-10.","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.295","article-title":"Trends in risks associated with new drug development: success rates for investigational drugs","volume":"87","author":"DiMasi JA","year":"2010","unstructured":"DiMasi JA, Feldman L, Seckler A, Wilson A. Trends in risks associated with new drug development: success rates for investigational drugs. Clin Pharmacol Ther. 2010, 87:272-7. 10.1038\/clpt.2009.295","journal-title":"Clin Pharmacol Ther"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113088","article-title":"The challenging melanoma landscape: from early drug discovery to clinical approval","volume":"10","author":"Matias M","year":"2021","unstructured":"Matias M, Pinho JO, Penetra MJ, Campos G, Reis CP, Gaspar MM. The challenging melanoma landscape: from early drug discovery to clinical approval. Cells. 2021, 10:3088. 10.3390\/cells10113088","journal-title":"Cells"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2018-0120","article-title":"Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities","volume":"14","author":"Farjadian F","year":"2019","unstructured":"Farjadian F, Ghasemi A, Gohari O, Roointan A, Karimi M, Hamblin MR. Nanopharmaceuticals and nanomedicines currently on the market: challenges and opportunities. Nanomedicine (Lond). 2019, 14:93-126. 10.2217\/nnm-2018-0120","journal-title":"Nanomedicine (Lond)"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2011.02.033","article-title":"Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles","volume":"85","author":"Cheow WS","year":"2011","unstructured":"Cheow WS, Hadinoto K. Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles. Colloids Surf B Biointerfaces. 2011, 85:214-20. 10.1016\/j.colsurfb.2011.02.033","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.3390\/pr9091527","article-title":"Challenges towards targeted drug delivery in cancer nanomedicines","volume":"9","author":"Hafeez MN","year":"2021","unstructured":"Hafeez MN, Celia C, Petrikaite V. Challenges towards targeted drug delivery in cancer nanomedicines. Processes. 2021, 9:1527. 10.3390\/pr9091527","journal-title":"Processes"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.1126\/science.1229568","article-title":"Minimal \"Self\" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles","volume":"339","author":"Rodriguez PL","year":"2013","unstructured":"Rodriguez PL, Harada T, Christian DA, Pantano DA, Tsai RK, Discher DE. Minimal \"Self\" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science. 2013, 339:971-5. 10.1126\/science.1229568","journal-title":"Science"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S36654","article-title":"Targeted therapy using nanotechnology: focus on cancer","volume":"9","author":"Sanna V","year":"2014","unstructured":"Sanna V, Pala N, Sechi M. Targeted therapy using nanotechnology: focus on cancer. Int J Nanomedicine. 2014, 9:467-83. 10.2147\/IJN.S36654","journal-title":"Int J Nanomedicine"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11121855","article-title":"Thirty years of cancer nanomedicine: success, frustration, and hope","volume":"11","author":"Salvioni L","year":"2019","unstructured":"Salvioni L, Rizzuto MA, Bertolini JA, Pandolfi L, Colombo M, Prosperi D. Thirty years of cancer nanomedicine: success, frustration, and hope. Cancers (Basel). 2019, 11:1855. 10.3390\/cancers11121855","journal-title":"Cancers (Basel)"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201201390","article-title":"Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking","volume":"9","author":"Duan X","year":"2013","unstructured":"Duan X, Li Y. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. Small. 2013, 9:1521-32. 10.1002\/smll.201201390","journal-title":"Small"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.8b00292","article-title":"Cellular uptake of nanoparticles versus small molecules: a matter of size","volume":"51","author":"Mosquera J","year":"2018","unstructured":"Mosquera J, Garc\u00eda I, Liz-Marz\u00e1n LM. Cellular uptake of nanoparticles versus small molecules: a matter of size. Acc Chem Res. 2018, 51:2305-13. 10.1021\/acs.accounts.8b00292","journal-title":"Acc Chem Res"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2018.01.047","article-title":"Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities","volume":"23","author":"Agrahari V","year":"2018","unstructured":"Agrahari V, Agrahari V. Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities. Drug Discov Today. 2018, 23:974-91. 10.1016\/j.drudis.2018.01.047","journal-title":"Drug Discov Today"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/295751-recent-advances-in-the-development-and-utilization-of-nanoparticles-for-the-management-of-malignant-solid-tumors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T11:06:20Z","timestamp":1727435180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/295751-recent-advances-in-the-development-and-utilization-of-nanoparticles-for-the-management-of-malignant-solid-tumors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":145,"URL":"https:\/\/doi.org\/10.7759\/cureus.70312","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}